First Wave BioPharma Inc

NASDAQ:FWBI   1:43:53 PM EDT
1.59
+0.03 (+1.92%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

First Wave BioPharma Inc Stock, NASDAQ:FWBI

777 Yamato Road, Suite 502, Boca Raton, Florida 33431
United States of America
Phone: +1.561.589.7020
Number of Employees: 12

Description

First Wave Biopharma, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of non-systemic therapies for the treatment of gastrointestinal diseases. The firm involves in therapeutic development pipeline populated with multiple clinical stage programs built around its proprietary technologies, such as Niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. Its programs include FW-UP, FW-UC, FW-CD,FW-COV, FW-ICI-AC, MS1819, COVID-19 GI infections, and FW-EPI. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.